A R T I C L E S
Ng et al.
(allyl Me), 39.7 (Xyl Me), 96.0 (allyl CH), 107.0 (C5Me5), 124.7 (Xyl
CH), 131.7 (Xyl CH), 139.3 (Xyl CH).
min via a cannula, whereupon the initial deep-red color of the solution
changed to orange/yellow after being stirred at -78 °C for 10 min.
The final mixture was then warmed to 0 °C, and the reaction was
allowed to proceed for 1 h. The solvent was then removed at 0 °C
over a period of 30 min. The residue was extracted with CH2Cl2 (3 ×
10 mL), and the combined extracts were filtered through an alumina-
(I) plug (2 × 3 cm) supported on a frit to obtain an orange filtrate. The
CH2Cl2 was removed from the filtrate under vacuum, and the residue
was recrystallized from a 2:1 Et2O/hexanes mix at -30 °C to obtain
complex 13 as yellow and orange blocks (138 mg, 52%).
9: 1H NMR (400 MHz, C6D6) δ 0.86 (s, 3H, allyl Me), 1.55 (s,
15H, C5Me5), 1.65 (bs, 3H, allyl Me), 1.77 (m, 1H, allyl CH2), 2.28 (s,
3H, Xyl Me), 2.34 (s, 3H, Xyl Me), 2.50 (m, 1H, allyl CH2), 3.56
(bm, 1H, allyl CH), 6.30 (bs, 1H, Xyl CH), 6.71 (s, 1H, Xyl CH), 8.04
(s, 1H, Xyl CH). 13C{1H} NMR (100 MHz, C6D6) δ 10.3 (C5Me5),
21.4 (Xyl Me), 21.6 (Xyl Me), 21.9 (allyl Me), 29.3 (allyl Me), 37.4
(allyl CH2), 95.6 (allyl CH), 107.3 (C5Me5), 125.6 (Xyl CH), 138.3
(Xyl CH), 140.0 (Xyl CH).
Cp*W(NO)(CH2C6H4-2-Me)(η3-1,1-Me2C3H3) (10), Cp*W(NO)-
(C6H3-2,3-Me2)(η3-1,1-Me2C3H3) (11), and Cp*W(NO)(C6H3-3,4-
Me2)(η3-1,1-Me2C3H3) (12). Complexes 10-12 were formed by the
thermolysis of 1 (205 mg, 0.42 mmol) in o-xylene. The resulting residue
following removal of solvent was an orange/yellow oil. Subsequent
workup and separation of products afforded complex 10 as orange
microcrystals (21 mg, 10%) and a mixture of complexes 11 and 12 as
orange/yellow microcrystals (56 mg, 26%).
13: IR (cm-1) 1552 (s, νNO). MS (LREI, m/z, probe temperature
1
120 °C) 509 [P+, 184W]. H NMR (500 MHz, C6D6) δ 1.04 (s, 3H,
allyl Me), 1.14 (s, 3H, allyl Me), 1.43 (s, 15H, C5Me5), 1.55 (br s, 1H,
2
allyl CH2), 1.78 (d, 1H, JHH ) 11.5, Bzl CH2), 2.46 (m, 1H, allyl
2
CH2), 2.81 (d, 1H, JHH ) 11.5, Bzl CH2), 3.52 (m, 1H, allyl CH),
7.03 (t, 1H, 3JHH ) 7.4, aryl p-CH), 7.32 (t, 2H, 3JHH ) 7.4, aryl m-CH),
7.71 (d, 2H, 3JHH ) 7.4, aryl o-CH). 13C{1H} NMR (125 MHz, C6D6)
δ 9.7 (C5Me5), 20.5 (allyl Me), 27.5 (allyl Me), 27.8 (Bzl CH2), 39.8
(allyl CH2), 97.9 (allyl CH), 106.4 (C5Me5), 123.1 (aryl p-CH), 127.7
(aryl m-CH), 130.4 (aryl o-CH), 153.4 (allyl C). Anal. Calcd for C22H31-
NOW: C, 51.88; H, 6.13; N, 2.75. Found: C, 51.95; H, 6.25; N, 2.86.
14-16: IR (cm-1) 1561 (s, νNO). MS (LREI, m/z, probe temperature
150 °C) 509 [P+, 184W]. Anal. Calcd for C22H31NOW: C, 51.88; H,
6.13; N, 2.75. Found: C, 51.84; H, 6.49; N, 2.85.
10: IR (cm-1) 1552 (s, νNO). MS (LREI, m/z, probe temperature
1
150 °C) 523 [P+, 184W]. H NMR (500 MHz, C6D6) δ 0.81 (m, 1H,
allyl CH2), 1.20 (s, 3H, allyl Me), 1.27 (s, 3H, allyl Me), 1.49 (s, 15H,
2
C5Me5), 2.04 (m, 1H, allyl CH2), 2.19 (d, 1H, JHH ) 10.7, Bzl CH2),
2
2.36 (d, 1H, JHH ) 10.7, Bzl CH2), 2.45 (s, 3H, Oxyl Me), 3.98 (m,
1H, allyl CH), 7.05 (m, 1H, Oxyl CH), 7.10 (obs 1H, Oxyl CH), 7.10
(obs, 1H, Oxyl CH), 7.23 (d, 1H, 3JHH ) 7.0, Oxyl CH). 13C{1H} NMR
(125 MHz, C6D6) δ 9.7 (C5Me5), 20.3 (allyl Me), 21.5 (Oxyl Me), 26.9
(allyl Me), 26.9 (Bzl CH2), 103.2 (allyl CH), 106.5 (C5Me5), 125.1
(Oxyl CH), 125.8 (Oxyl CH), 129.0 (Oxyl CH), 130.1 (Oxyl CH). Anal.
Calcd for C23H33NOW: C, 52.78; H, 6.36; N, 2.68. Found: C, 53.02;
H, 6.36; N, 2.92.
11,12: IR (cm-1) 1552 (s, νNO). MS (LREI, m/z, probe temperature
150 °C) 523 [P+, 184W]. Anal. Calcd for C23H33NOW: C, 52.78; H,
6.36; N, 2.68. Found: C, 52.93; H, 6.37; N, 2.61.
14: 1H NMR (400 MHz, C6D6) δ 2.26 (s, 3H, Tol Me), 3.55 (br m,
3
1H, allyl CH), 6.47 (br s, 1H, Tol CH), 6.88 (d, 1H, JHH ) 7.1, Tol
3
3
CH), 7.25 (t, 1H, JHH ) 7.1, Tol CH), 8.21 (d, 1H, JHH ) 7.1, Tol
CH). 13C{1H} NMR (100 MHz, C6D6) δ 10.2 (C5Me5), 21.7 (Tol Me),
95.8 (allyl CH), 106.9 (C5Me5), 124.8 (Tol CH), 128.0 (obs, Tol CH),
139.5 (Tol CH), 141.2 (Tol CH).
15: 1H NMR (400 MHz, C6D6) δ 2.35 (s, 3H, Tol Me), 3.55 (br m,
3
1H, allyl CH), 6.47 (br s, 1H, Tol CH), 6.94 (d, 1H, JHH ) 6.6, Tol
CH), 7.16 (obs, 1H, Tol CH), 8.24 (s, 1H, Tol CH). 13C{1H} NMR
(100 MHz, C6D6) δ 10.2 (C5Me5), 21.9 (Tol Me), 95.8 (allyl CH), 106.9
(C5Me5), 123.5 (Tol CH), 126.9 (Tol CH), 137.2 (Tol CH), 143.1 (Tol
CH).
11: 1H NMR (400 MHz, C6D6) δ 0.85 (s, 3H, allyl Me), 1.55 (s,
15H, C5Me5), 1.59 (s, 3H, allyl Me), 1.76 (obs, 1H, allyl CH2), 2.21
(br s, 6H, 2 Xyl Me), 2.50 (m, 1H, allyl CH2), 3.56 (br m, 1H, allyl
3
16: 1H NMR (400 MHz, C6D6) δ 2.28 (s, 3H, Tol Me), 3.55 (br m,
CH), 6.45 (br s, 2H, 2 Xyl CH), 7.07 (d, 1H, JHH ) 7.4, Xyl CH).
13C{1H} NMR (100 MHz, C6D6) δ 10.3 (C5Me5), 19.6 (Xyl Me), 19.8
(Xyl Me), 24.7 (allyl Me), 28.4 (allyl Me), 37.4 (allyl CH2), 95.9 (allyl
CH), 106.9 (C5Me5), 128.8 (Xyl CH), 137.8 (Xyl CH), 141.7 (Xyl CH).
12: 1H NMR (400 MHz, C6D6) δ 0.88 (s, 3H, allyl Me), 1.55 (s,
15H, C5Me5), 1.65 (br s, 3H, allyl Me), 1.76 (obs, 1H, allyl CH2), 2.18
(s, 3H, Xyl Me), 2.27 (s, 3H, Xyl Me), 2.50 (m, 1H, allyl CH2), 3.56
(br s, 1H, allyl CH), 7.13 (obs, 1H, Xyl CH), 8.17 (obs, 1H, Xyl CH),
8.19 (s, 1H, Xyl CH). 13C{1H} NMR (100 MHz, C6D6) δ 10.3 (C5Me5),
19.5 (Xyl Me), 19.8 (Xyl Me), 21.8 (allyl Me), 29.4 (allyl Me), 37.3
(allyl CH2), 95.8 (allyl CH), 106.9 (C5Me5), 130.2 (Xyl CH), 140.2
(Xyl CH), 143.7 (Xyl CH).
3
1H, allyl CH), 6.58 (br s, 1H, Tol CH), 7.08 (d, 1H, JHH ) 6.6, Tol
3
CH), 7.16 (obs, 1H, Tol CH), 8.31 (d, 1H, JHH ) 7.1, Tol CH). 13C-
{1H} NMR (100 MHz, C6D6) δ 10.2 (C5Me5), 21.5 (Tol Me), 95.8
(allyl CH), 106.9 (C5Me5), 128.0 (obs Tol CH), 129.6 (Tol CH), 140.1
(Tol CH), 142.4 (Tol CH).
Cp*W(NO)(η4-trans-H2CdCHC(Me)dCH2) (17). Preparation of
this η4-trans-diene tungsten complex was accomplished by using a
modified version of the previously published procedure and employing
isoprene as the trapping agent.55 Previous research in this group has
shown that the likelihood of forming the cis-isomer was unlikely,
because similar cis-diene complexes that had been prepared spontane-
ously isomerized to the thermodynamically more stable trans form.56-58
In a thick-walled bomb, Cp*W(NO)(CH2SiMe3)259 (401 mg, 0.77 mmol)
was dissolved in pentane (60 mL), and isoprene (3 mL, 30 mmol) was
syringed into the reaction vessel. The resulting mixture was frozen using
a liquid N2 bath, and H2 gas (14 psig) was then introduced. The contents
of the bomb were allowed to warm to room temperature and react while
being stirred overnight. After 16 h, the final mixture was concentrated
and cooled to obtain yellow crystals of 17 (20 mg, 6%).
Cp*W(NO)(CH2C6H5)(η3-1,1-Me2C3H3) (13), Cp*W(NO)(C6H4-
2-Me)(η3-1,1-Me2C3H3) (14), Cp*W(NO)(C6H4-3-Me)(η3-1,1-Me2C3H3)
(15), and Cp*W(NO)(C6H4-4-Me)(η3-1,1-Me2C3H3) (16). Complexes
13-16 were prepared via the thermolysis of 1 (200 mg, 0.41 mmol) in
toluene. After the 6-h reaction period, the resulting solution was a dark
orange/brown color which yielded a brown oil upon solvent removal
under vacuum. Subsequent workup and separation of products afforded
complex 13 and a mixture of complexes 14-16 as orange/yellow blocks
(156 mg, 75%).
Complex 13 was prepared by a method similar to the procedure
published for Cp*W(NO)(CH2C6H5)(CH2CMe3).20 In the glovebox, a
100-mL Schlenk tube was charged with a magnetic stir bar and (1,1-
Me2C3H3)2Mg‚x(dioxane) (103 mg, 0.53 mmol). A 200-mL Schlenk
tube was then charged with a stir bar and Cp*W(NO)(CH2C6H5)Cl (250
mg, 0.53 mmol). On a vacuum line, THF (80 mL) was vacuum
transferred into the Schlenk tube containing the organometallic halide
and into the Schlenk tube with the magnesium reagent (10 mL). The
two resulting solutions were then mixed at -78 °C over a period of 5
17: IR (Nujol, cm-1) 1560 (w, νNO). MS (LREI, m/z, probe
1
temperature 120 °C) 417 [P+, 184W]. H NMR (400 MHz, C6D6) δ
(55) Debad, J. D.; Legzdins, P.; Young, M. A. J. Am. Chem. Soc. 1993, 115,
2051.
(56) Hunter, A. D.; Legzdins, P.; Nurse, C. R. J. Am. Chem. Soc. 1985, 107,
1791.
(57) Hunter, A. D.; Legzdins, P.; Nurse, C. R.; Einstein, F. W. B.; Willis, A.
C.; Bursten, B. E.; Gatter, M. J. J. Am. Chem. Soc. 1986, 108, 3843.
(58) Christensen, N. J.; Hunter, A. D.; Legzdins, P. Organometallics 1989, 8,
930.
(59) Legzdins, P.; Rettig, S. J.; Sanchez, L. Organometallics 1988, 7, 2394.
9
15220 J. AM. CHEM. SOC. VOL. 125, NO. 49, 2003